	US 12,246,072 B2
	Gene therapy for the treatment of CNGB1-linked retinitis pigmentosa
Stylianos Michalakis, Munich (DE); and Martin Biel, Munich (DE)
Assigned to Stylianos Michalakis, Munich (DE); and Martin Biel, Munich (DE)
Appl. No. 16/495,826
Filed by Stylianos Michalakis, Munich (DE); and Martin Biel
PCT Filed Mar. 21, 2018, PCT No. PCT/IB2018/051905 § 371(c)(1), (2) Date Sep. 19, 2019, PCT Pub. No. WO2018/172961, PCT Pub. Date Sep. 27, 2018.
Claims priority of provisional application 62/474,409, filed on Mar. 21, 2017.
Prior Publication US 2020/0030458 A1, Jan. 30, 2020
Int. Cl. A61K 48/00 (2006.01); A61P 27/02 (2006.01); C07K 14/705 (2006.01); C12N 15/86 (2006.01)

CPC A61K 48/0058 (2013.01) [A61P 27/02 (2018.01); C07K 14/705 (2013.01); C12N 15/86 (2013.01); A01K 2267/0306 (2013.01)]

4 Claims

1. A vector comprising the nucleic acid sequence of SEQ ID NO: 43.